Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
237 participants
OBSERVATIONAL
2020-01-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators wish to characterize it among our population, and assess its consequenses and the postnatal menagement of the infants.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Monitoring Outcome in Neonatal Thrombocytopenia
NCT03110887
Observational Study of Infants Born at 34 to 37 Weeks of Gestation Until the Age of 1 Year
NCT00550069
Weaning Preterm Infants at 1500 Grams From Incubators
NCT01083303
Normal Hemostasis Values in Premature Infants
NCT07349251
Nasogastric Tube vs. Orogastric Feeding Tube in Preterm Infants: Which is Best?
NCT00365703
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators wish to characterize it among our population, and assess its consequenses and the postnatal menagement of the infants.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Late neutropenia
Neutrophil count \< 1500
No intervention
No intervention
No late neutropenia
Neutrophil count \> 1500
No intervention
No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
30 Days
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hillel Yaffe Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Erez Nadir, MD
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erez Nadir, MD
Role: PRINCIPAL_INVESTIGATOR
Hillel Yaffe Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hillel Yaffe medical center
Hadera, Hadera, Israel
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Juul SE, Calhoun DA, Christensen RD. "Idiopathic neutropenia" in very low birthweight infants. Acta Paediatr. 1998 Sep;87(9):963-8. doi: 10.1080/080352598750031635.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0160-19-HYMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.